Android
Zerodha Broker (Free Delivery)

India's No. 1 Broker with Best Software Trade @ Flat Rs 20

Open Instant Account
market update arrow Govt's meeting with farmers ends in deadlock; next round of talks on Dec 3 arrow We never mentioned we'd vaccinate entire population, says Health ministry arrow Addressable market for OEMs likely to be over Rs 10 trn by 2025: Report arrow Coronavirus LIVE: 4,006 new Covid-19 cases, 86 deaths in Delhi today arrow Farmers' protests LIVE: Unions reject Centre's proposal to set up panel arrow RBI likely to keep policy rates unchanged, liquidity stance awaited arrow Neera Tanden, Biden's pick as budget chief, faces tough confirmation test arrow Diwali props up two-wheeler sales in November, top-six firms post 16% spike arrow Bitcoin's rally spurs Wall Street to question future of Gold arrow With Kataria at Bata helm, Indian-origin corporate honchos expand footprint arrow Bookings on Mumbai-bound flights decline by 20% on Covid-19 curbs arrow OECD cuts India's FY21 GDP contraction rate to 9.9% from 10.2% earlier arrow Reliance Industries tops Fortune India-500 list second year in a row arrow Shree Cement, Motherson Sumi, Sundram Fasteners hit 52-wk highs arrow GST collections up Rs 1 trn for second month straight, aided by festivals arrow ABB Power zooms 33% in 3 days on tie-up with Ashok Leyland for e-bus pilot arrow Burger King India IPO opens for subscription tomorrow. Should you invest? arrow Trifo Max review: A robot vacuum cleaner that doubles up as security camera arrow World Coronavirus Dispatch: Unrest in Sri Lanka's cramped prisons arrow YES Bank trades at its highest level since August 31; zooms 26% in 1 month arrow DATA STORY: India's active cases fall to 435,603, the lowest since July 23 arrow Sun Pharma rallies 6%, inches towards 52-week high on heavy volumes arrow Tech Mahindra hits new high on healthy growth outlook, 5G opportunities arrow Tata Steel Long Products soars 10% as Tata Steel completes open market sale arrow Cement shares extend rally; Shree Cement, JK Cement hit new lifetime highs

ASTRAZENECA PHARMA INDIA LTD.4528.45 -10.45 (-0.23%)

  • BSE: 506820
  • |
  • NSE: ASTRAZEN
  • |
  • ISIN NO: INE203A01020
  • |
  • INDUSTRY: Pharmaceuticals
Profile

ASTRAZEN

Chairman: Narayan K Seshadri

Founded: 1979

Headquarters: Bengaluru, Karnataka

Parent organizationAstra Pharmaceuticals AB

Employees: 1325

Profile

AstraZeneca Pharma India Limited is a global biopharmaceutical company. 

The Company is engaged in the discovery, development, and commercialization of medicines for healthcare, including cardiovascular/metabolic disease, cancer, and respirat ... ory, inflammatory, and autoimmune disease. 

The Company operates through two segments: 

a. Healthcare.

b. Clinical Trial. 

The Healthcare segment engages in the manufacture and sale of pharmaceutical products. 

The Clinical Trial segment renders clinical trial services on pharmaceutical products to its group companies. 

 

 

Awards and Achievements

  1. It was promoter jointly by Astra Pharmaceuticals AB Sweden (Astra), and IDL Chemicals Ltd Hyderabad.
  2. 1980: The Company entered into a technical collaboration with Astra
  3. The Company supply for information and know-how and all manufacturing process and technical data for the manufacture of basic drugs, formulations, fine chemicals, and industrial chemicals.
  4. The Company undertook to set up a project at Yelahanka Bangalore for the manufacture of basic drugs, formulations, fine including industrial chemicals. 
  5. 1982: The pharmaceuticals and chemicals plant was commissioned in February
  6. 1982-2,000: shares issued to promoters etc. 24,98,000 shares issued at par 6,43,235 shares each allotted to Astra Pharmaceuticals AB Sweden and IDL Chemicals Ltd 3,78,830 shares allotted to Indian directors, shareholders, and employees, shareholders, and employees, etc. of the company and 8,32,700 shares offered for public subscription.
  7. 1988: The Company launched `SENSORCAINE' a long-acting local anesthetic for use in surgical anesthesia and introduced`THEOBRIC' a combination of Branco dilator for asthma. 
  8. The Company launched`RESTOMYCIN' an antibiotic
  9. `BROMENYL' cough expectorant and `FEBRAFEN' for pain and fever.
  10. The Company launched `PROSTODIN'the first prostaglandin with an important indication for postpartum hemorrhage etc. Several new products were launched during the year, namely, SELOPRES, BETALOC DURULES, TRIPRES, SENSORCAINE SPINAL, and BRICANYL, NEBULISING SOLUTION. 
  11. It launched products based on inhalation therapy such as `PULMICORTINHALER' BRICANYL INHALER and SPACEHALER.
  12. 1991: The Company launched a product in the Prostaglandins range`PIMIPROST' for the promotion of safe motherhood.
  13. 1992: The Company launched Prostaglandin`Cerviprime Gel' for cervical ripening and `Plendil' a new generation calcium antagonist. 
  14. 1994: The Company proposed to launch Ramace, Rhinocort, and Imdur. which strengthens the cardiovascular range of products. 
  15. 1995: 25,00,000 bonus shares issued in prop. 1:1.
  16. 1996: Two new lines of extension namely Jumbo pack of Pulmicort & Bricanyl Inhalers 400 metered doses were introduced in the respiratory group. 
  17. 1997: A range of new products viz Xylocaine Spray in the pain control segment, Stop-it in the Anti-infective segment.
  18. A joint venture between the US $ 7-billion Swedish pharmaceutical major Astra AB and IDL Industries of the Hindujas.
  19. 1998: Wipro, Honda Siel Power Products, and Astra-IDL have been conferred the Analyst Awards by The Institute of Chartered Financial Analysts of India (ICFAI).
  20. 1999: Even as the Hindujas continue to seek new alignments to replace multinational AstraZeneca in their joint venture Astra IDL Ltd.
  21. 2000: UB's 100 percent subsidiary, UB Bioteck has tied up with Astra IDL Ltd to market its newly-patented anti-obesity nutraceutical.
  22. Mr. D.E. Udwadia, the Director, has been appointed as the Chairman.
  23. 2001: Crisil has placed the `FAA' rating on the fixed deposit program of the company on a rating watch with positive implications.
  24. The Company upon the acquisition Astra Sweden now holds 51.50 percent of the company's issued and paid-up equity shares capital. 
  25. The company is a subsidiary of Astra Sweden and has become a part of the worldwide AstraZeneca Group.
  26. The Managing Director Mr. A.R. Hegde, has resigned from the company.
  27.  Astra IDL Ltd renamed AstraZeneca Pharma India Ltd  
  28. 2002: Ties up with Avestha for research on discovering drugs for tuberculosis.
  29. Makes an open offer to acquire the balance of 21,75,050 equity shares of AstraZeneca Pharma India Ltd representing a 43% stake.
  30. Government FDI proposal for the company and Tata Home finance from 56.69% to 100% accounting for Rs.82 Crs.
  31. Astra Pharma acquires 32800 equity shares of AstraZeneca.
  32. 2003: Astra Pharma and AstraZeneca jointly acquire less than 4% additional equity Astrazeneca Pharma India Ltd.
  33. Sir Tom McKillop inaugurates R & D center in Bangalore for $40 million.
  34. Approaches the Union government for Exclusive Marketing rights for new generation anti-cancer drugs.
  35. 2006: AstraZeneca acquires Eli Lilly's Vancocin brand company has split its face value of shares from Rs 10 
  36. 2007: AstraZeneca Pharma India Ltd has appointed Mr. Ruud Dobber as director of the company.
  37. 2010: AstraZeneca Pharma and biopharmaceutical company Bristol Myers Squibb launched their 9-month old diabetes drug Onglyza in India. Onglyza, or saxagliptin, is used to treat two types of diabetes in adults. 
  38. 2011: AstraZeneca Halts Late-stage trial of Prostate Cancer Medicine Zibotentan
  39. 2012: AstraZeneca Excellence in Chemistry Awards 2011
  40. AstraZeneca launches its patented life-saving heart drug BRILINTA (Ticagrelor) in India
  41. 2013: AstraZeneca to acquire Bristol Myers Squibb's share of global diabetes alliance assets.
  42. 2014: AstraZeneca and Bristol Myers Squibb Company announced the US Food and Drug Administration (FDA) approved FARXIGA™ (dapagliflozin).
  43. AstraZeneca and MRC enter strategic collaboration to create a new center for early drug discovery in Cambridge, UK.
  44. AstraZeneca opens new manufacturing facility to support continued growth in Russia

 

Read More
Key Data
  • Market cap 11006.00 CR.
  • Book value 145.78
  • Stock P/E 163
  • Dividend Yield 0.05%
  • ROCE 33.92%
  • ROE 21.66%
  • Sales Growth (3Y) 15.23%
  • Face Value (3Y) 2.00
Trend Analysis
  • Short Term Trend :
    Up
  • Medium Term Trend :
    Up
  • Long Term Trend :
    Not Clear

Are you friends with trend?

There is a saying in stock market, "Trend is your best friend"

It means, a good trader doesn't place his money against the trend. Many new traders lose money because they are trying to catch trend reversals but seasoned traders wait for a clear trend to emerge before taking the trade in the direction of trend.

Day Technicals

What is Opening Range Breakout?

An opening range breakout is breaking out of the day's range after a stock has moved for some time in a sideways trend. In technical terms, its a breakout from the support and resistance level in an upward or downward trend.

NR7

What is NR7 trading strategy?

Narrow Range trading strategy or NR7 Trading strategy is a breakout based method which assumes that the price of security trends up or down after a brief consolidation in a narrow range.

Opening Price clues

How to use Opening Price Clues in your trades?

If the stock has same open and high after it has traded for some time, it implies there was a consistent selling pressure that didn't allow the stock to move higher from the opening price. Similarly, if the stock has same open and low price, it implies there was a consistent buying intent that kept the stock price above the opening price.

Day High Low Range
TIME LOWEST HIGHEST
10 AM 4505.20 4578.00
11 AM 4505.20 4578.00
12 PM 4505.20 4578.00
1 PM 4505.20 4578.00
2 PM 4505.20 4578.00
3 PM 4505.20 4578.00
Japanese Candlestick Patterns
Candle Pattern 1 :None
Candle Pattern 2 : None
Candle Pattern 3 :None
Candlestick Price Action
Higher High Higher Low
Pivot Points
Name S4 S3 S2 S1 Pivot Points R1 R2 R3 R4
classic 3974.30 4151.30 4328.30 4433.60 4505.30 4610.60 4682.30 4859.30 5036.30
woodie's 4057.50 4234.50 4317.25 4411.50 4494.25 4588.50 4671.25 4765.50 4942.50
fibonacci - 4328.30 4395.88 4437.69 4505.30 4572.91 4614.72 4682.30 -
camarilla 4441.55 4490.22 4506.45 4522.68 -- 4555.12 4571.35 4587.58 4636.25
Past Performance & Moving Averages
Day’s LOW HIGH RANGE SMA PERFORMANCE Nifty
10 DAY 4331.05
4612.95
4458.52 3.04 % 1.12 %
20 DAY 4180.00
4612.95
4364.03 8.59 % 3.16 %
50 DAY 4126.30
4612.95
4331.53 7.81 % 9.28 %
100 DAY 3250.00
4970.00
3946.12 35.49 % 13.66 %
200 DAY 1885.00
4970.00
3413.33 51.30 % 43.30 %
YTD 1885.00
4970.00
3303.63 54.12 % 6.61 %
52 Week 1632.55
4970.00
2910.56 54.12 % 7.86 %

Why are moving Averages important in technical Analysis?

An opening range breakout is breaking out of the day's range after a stock has moved for some time in a sideways trend. In technical terms, its a breakout from the support and resistance level in an upward or downward trend.

Gaps On Day Chart
Unfilled Gap Up On 2020-06-05
3150.00 ~ 3130.00 SUPPORT
Unfilled Gap Up On 2020-03-31
2300.00 ~ 2290.00 SUPPORT
Industry Growth Rate

In Last 1 Year the industry has grown by 10.56 %

In Last 5 Year the industry has grown by 12.36 %

Peer comparison

Sales

COMPANY NAME 2014 2015 2016 2017 2018 2019
SUNPHARMA 16080.00 27392.00 28487.00 31578.00 26489.00 29066.00
LUPIN 11286.00 12770.00 14256.00 17367.00 15797.00 16718.00
CIPLA 10173.00 11345.00 13790.00 14394.00 15156.00 16362.00
AUROPHARMA 8089.00 12103.00 13772.00 14910.00 16463.00 19564.00
Total 11407.00 15902.50 17576.25 19562.25 18476.25 20427.50

Financial

LAST FISCAL CURRENT GROWTH 10 YEAR CAGR
S.NO. COMPANY NAME MARKET CAP CMP BOOK VALUE EPS STOCK P/E ROE ICR REVENUE NET PROFIT NPM REVENUE NET PROFIT REVENUE NET PROFIT
1 SUN PHARMACEUTICAL INDUSTRIES LTD. 129519.74 539.75 98.33 11.11 38.37 11.10 11.45% 29066.00 2665.00 9.17% 9.73% 27.15% 21.39% 3.90%
2 MARKSANS PHARMA LTD. 92969.02 22.65 11.85 1.87 10.83 1.85 13.20% 1000.00 76.00 7.60% 9.53% 130.30% 10.88%
3 MOREPEN LABORATORIES LTD. 71575.87 15.90 6.43 0.64 23.05 0.32 34.00% 769.00 29.00 3.77% 26.69% 15.56%
4 NEULAND LABORATORIES LTD. 50071.35 390.75 542.16 12.74 36.68 1.23 3.63% 667.00 16.00 2.40% 26.57% 33.33% 8.07% 2.92%
5 GUFIC BIOSCIENCES LTD. 41419.69 53.30 10.85
6 DIVI'S LABORATORIES LTD. 95925.49 3615.00 266.77 50.96 38.52 25.53 374.60% 4946.00 1353.00 27.36% 27.11% 54.28% 15.41% 12.49%
7 DR.REDDY'S LABORATORIES LTD. 80302.75 4833.50 852.69 117.47 26.67 23.49 35.71% 15448.00 1950.00 12.62% 8.17% 105.91% 8.45%
8 RPG LIFE SCIENCES LTD. 41788.21 252.45 105.02
9 SMS PHARMACEUTICALS LTD. 34236.68 40.25 42.07 4.73 8.97 5.00 7.50% 465.00 40.00 8.60% 0.43% 25.00%
10 CIPLA LTD. 60894.75 755.55 209.71 18.96 23.60 9.49 18.43% 16362.00 1528.00 9.34% 7.96% 8.29% 12.67% 7.08%
11 TORRENT PHARMACEUTICALS LTD. 44907.76 2652.55 323.66 25.78 77.62 5.13 3.86% 7673.00 436.00 5.68% 28.96% 16.89% 9.01%
12 PIRAMAL ENTERPRISES LTD. 31887.38 1413.75 823.58 70.51 20.69 39.81 1.61% 13215.00 1473.00 11.15% 24.31% 15.08% 16.64%
13 LUPIN LTD. 41222.69 909.75 384.76 13.40 53.92 6.74 9.28% 16718.00 607.00 3.63% 5.83% 141.83% 16.04% 1.92%
14 NECTAR LIFESCIENCES LTD. 29495.44 13.16 49.89 2.12 6.56 2.18 1.78% 2779.00 48.00 1.73% 48.29% 14.38%
15 AUROBINDO PHARMA LTD. 52547.41 897.25 206.07 40.36 12.59 40.08 15.03% 19564.00 2365.00 12.09% 18.84% 20.53% 37.21%
16 Alkem Laboratories Ltd 33585.86 2797.65 501.34 63.61 37.53 31.71 20.36% 7357.00 761.00 10.34% 14.94% 20.60%
17 ABBOTT INDIA LTD. 32855.33 15409.00 1004.00
18 CADILA HEALTHCARE LTD. 46440.02 453.45 90.85 18.05 15.05 18.13 15.32% 13166.00 1849.00 14.04% 10.59% 4.11% 16.49% 19.83%
19 GLAXOSMITHKLINE PHARMACEUTICALS LTD. 26233.44 1548.90 138.61 26.29 52.38 2.63 581.00% 3128.00 445.00 14.23% 8.95% 26.78%
20 KILITCH DRUGS (INDIA) LTD. 13893.00 89.90 98.74 2.49 51.55 0.25 11.22% 82.40 3.83 4.65% 61.70%
Sales

What is Sales Trend ?

Sales trend is a methodology to understand sales results which helps in understanding the trends of the market over a specific period of time. Sales results are an indicative of the sales patterns followed by the customer over a time period.

Profitability

What is Profit & EPS Trend ?

EPS Trends was initially built in late 2015 when I was just getting into frontend development. Coming from a background in Rails, I was frustrated with how many decisions you had to make early on as a javascript developer.

Net Profit
EPS

What is EBITDA Margin & EBIT Margin ?

Corporate accounting is required to adhere to the standards and practices collectively referred to as the generally accepted accounting principles. EBITDA is an excellent way for corporate accountants to start compiling data, but it should not be considered an absolute result. This is due to the fact that many consider EBITDA more of a broad stroke than a definitive form of accounting practice.

EBITDA Margin
EBIT Margin
NPM
Cash Flow

Why is the Cash Flow Analysis important?

A business needs cash to pay its expenses, to pay bank loans, to pay taxes and to purchase new assets. A cash flow report determines whether a business has enough cash to do exactly this.

Operating Activities
Financing Activities
Investing Activities
Financial Health

What Is Financial Health?

Financial health is a term used to describe the state of one's personal monetary affairs. There are many dimensions to financial health, including the amount of savings you have, how much you’re putting away for retirement, and how much of your income you are spending on fixed or non-discretionary expenses.

Debt to Equity
Piotroski Score
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9

What Is the Piotroski Score?

The Piotroski score is a discrete score between 0-9 that reflects nine criteria used to determine the strength of a firm's financial position.

Altman Z Score (Mfg Company)
  • Distress (< 1.81)
  • Caution (>1.81 < 2.99)
  • 17.05
    Safe (3 & above)
Altman Z Score (Non-Mfg Company)
  • Distress ( < 1.23)
  • Caution (>1.23 < 2.6)
  • 29.59
    Safe (2.6 & above)
Valuation

What Is Valuation?

Valuation is the analytical process of determining the current (or projected) worth of an asset or a company. There are many techniques used for doing a valuation. An analyst placing a value on a company looks at the business's management, the composition of its capital structure, the prospect of future earnings, and the market value of its assets, among other metrics.

What is the significance of Rollover data?

Rollover in an important data point and should be analyzed in the expiry week. Rollover involves carry forwarding of ‘futures’ positions from one series (which is nearing expiry date) to the next one.

Rollover percentage actually indicates whether the traders are willing to carry forward their existing. positions (long or short) to the next series or not. Generally, the rollover figures alone will not indicate which direction traders are betting on. You should also check whether absolute open interest is increasing or decreasing over expiries

What is Options Max Pain Theory?

Options Max Pain Theory suggests,

“On option expiration day, the underlying stock price often moves toward a point that brings maximum loss to option buyers.”

Ratio Analysis

The Bank was incorporated in the year 2004 by Rana Kapoor and Late Ashok Kapur, which is a new age private sector bank. And since the inception of the bank has fructified into a “Full-Service Commercial Bank,” it has steadily built Corporate and Institutional Banking, Financial Markets, Investment Banking, Corporate Finance, Branch Banking, Business and Transaction Banking, and Wealth Management business lines across the whole country.

It is well-equipped to offer a spectrum of products and services to all the corporate and retail customers.

Read More
Bulk Deals
Symbol Name Deal Date Client Name Transcation Type Quantity Price
ASTRAZEN 2013-05-30 CROSSEAS CAPITAL SERVICES PRIVATE LIMITED S 126180.00 845.63
Block Deals
Symbol Name Deal Date Client Name Transcation Type Quantity Price
Dividend history
Ex Date Amount
2019-08-20 1.00
2012-07-09 3.50
2011-07-07 10.00
2010-05-06 10.00
2009-04-29 15.00
2008-04-11 15.00
2001-06-18 4.00
2000-08-11 0.50
Bonus Data
Company Name Split Date From Value To Value
Split Data
Company Name Split Date From Value To Value